YD Bio Limited Warrants (YDESW)
Stock · NASDAQ · Health Care
$0.4173as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Industry
Medical Specialities
YD Bio Limited Warrants Competitors
Chosen by industry and closest market cap.
- YDESWYD Bio Limited Warrants$0.4173▲ 19.23%Market cap $16.29MP/E —
- SERASera Prognostics Inc. Class A Common Stock$2.07▲ 0.49%Market cap $78.32MP/E —$1.56$3.95
- BNRBurning Rock Biotech Limited American Depositary Shares$10.19▲ 1.90%Market cap $93.65MP/E —$6.79$41.72
- KEQUKewaunee Scientific Corporation Common Stock$37.78▼ 0.50%Market cap $108.73MP/E 10.89$33.27$59
- XGNExagen Inc. Common Stock$7.38▼ 1.86%Market cap $159.64MP/E —
- ACHAccendra Health Inc. Common Stock$1.22▲ 0.83%Market cap $223.62MP/E —$0.9337$5.69
- TLSITriSalus Life Sciences Inc. Common Stock$4.85▼ 1.62%Market cap $299.10MP/E —$2.2$7.95
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| YDESW YD Bio Limited Warrants | $16.29M | — | $0.4173 | ▲ 19.23% | |
| SERA Sera Prognostics Inc. Class A Common Stock | $78.32M | — | $2.07 | ▲ 0.49% | $1.56$3.95 |
| BNR Burning Rock Biotech Limited American Depositary Shares | $93.65M | — | $10.19 | ▲ 1.90% | $6.79$41.72 |
| KEQU Kewaunee Scientific Corporation Common Stock | $108.73M | 10.89 | $37.78 | ▼ 0.50% | $33.27$59 |
| XGN Exagen Inc. Common Stock | $159.64M | — | $7.38 | ▼ 1.86% | |
| ACH Accendra Health Inc. Common Stock | $223.62M | — | $1.22 | ▲ 0.83% | $0.9337$5.69 |
| TLSI TriSalus Life Sciences Inc. Common Stock | $299.10M | — | $4.85 | ▼ 1.62% | $2.2$7.95 |
P/E shows — for peers not currently carrying a live signal of their own.
See the full, filterable feed with live charts on the MarketWall dashboard.